World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
72
Citations
16580
World Ranking
6385
National Ranking
2988

Overview

David L. Nelson is affiliated with Baylor College of Medicine in the United States. Their research primarily spans the field of Biochemistry, Genetics and Molecular Biology, with a total of 34 publications in this area.

The subfields that David L. Nelson has contributed to include:

  • Molecular Biology
  • Genetics
  • Cognitive Neuroscience
  • Ecology
  • Cell Biology

The topics addressed in their work cover a diverse range of scientific inquiries:

  • Genetics and Neurodevelopmental Disorders
  • Autism Spectrum Disorder Research
  • Flood Risk Assessment and Management
  • Hydrology and Watershed Management Studies
  • Hydrology and Sediment Transport Processes
  • RNA modifications and cancer
  • Genomics and Phylogenetic Studies

David L. Nelson has contributed to several recent papers that illustrate the scope and diversity of their research interests. These include:

  • International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function, 2020, published in Pharmacological Reviews
  • LLPS of FXR1 drives spermiogenesis by activating translation of stored mRNAs, 2022, published in Science
  • Characterization and visualization of tandem repeats at genome scale, 2024, published in Nature Biotechnology
  • Intercepting IRE1 kinase-FMRP signaling prevents atherosclerosis progression, 2022, published in EMBO Molecular Medicine
  • Resolving the unsolved: Comprehensive assessment of tandem repeats at scale, 2023, published in bioRxiv (Cold Spring Harbor Laboratory)

Research dissemination by David L. Nelson frequently appears in the following publication venues:

  • Proceedings of the National Academy of Sciences
  • Journal of Earth Science
  • The American Journal of Human Genetics
  • Pharmacological Reviews
  • Science

The scientist has collaborated repeatedly with several coauthors, highlighting ongoing research partnerships. Notable frequent coauthors include:

  • Peng Jin
  • Yanghong Gu
  • Robert E. Criss
  • Evan E. Eichler
  • Nitzan Yanay

Best Publications

  • Risk factors for cerebral edema in children with diabetic ketoacidosis.

    Nicole Glaser;Peter Barnett;Ian Mccaslin;David Nelson

  • The soluble interleukin-2 receptor: biology, function, and clinical application.

    Laurence A. Rubin;David L. Nelson

  • The Sézary syndrome: a malignant proliferation of helper T cells.

    S Broder;R L Edelson;M A Lutzner;D L Nelson

  • Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation.

    Yinzhu Jin;Cinzia Mazza;Cinzia Mazza;Cinzia Mazza;Jacinda R. Christie;Jacinda R. Christie;Jacinda R. Christie;Silvia Giliani;Silvia Giliani;Silvia Giliani

  • Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.

    T A Waldmann;J D White;J A Carrasquillo;J C Reynolds

  • A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac.

    Laurence A. Rubin;Carole C. Kurman;William E. Biddison;Neil D. Goldman

  • Identification and Modification of Environmental Noise in an ICU Setting

    Douglas M. Kahn;Thorley E. Cook;Carol C. Carlisle;David L. Nelson

  • Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency.

    Qiang Pan-Hammarström;Ulrich Salzer;Likun Du;Jan Fredrik Björkander

  • Cdc42-interacting Protein 4 Mediates Binding of the Wiskott-Aldrich Syndrome Protein to Microtubules

    Lan Tian;David L. Nelson;Donn M. Stewart

  • The human interleukin-2 receptor: normal and abnormal expression in T cells and in leukemias induced by the human T-lymphotropic retroviruses.

    Warner C. Greene;Warren J. Leonard;Joel M. Depper;David L. Nelson

  • Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy.

    James M. Pluda;David J. Venzon;Giovanna Tosato;Jill Lietzau

  • International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function

    Nicholas M. Barnes;Gerard P. Ahern;Carine Becamel;Joël Bockaert

  • Activated lymphocytes during acute Epstein-Barr virus infection.

    Blake E. Tomkinson;David K. Wagner;David L. Nelson;John L. Sullivan

  • An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro

    David L. Nelson;Laurence A. Rubin;Carole C. Kurman;Mary E. Fritz

  • Somatic mosaicism in Wiskott–Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism

    Taizo Wada;Shepherd H. Schurman;Makoto Otsu;Elizabeth K. Garabedian

  • Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival.

    D K Wagner;J Kiwanuka;B K Edwards;L A Rubin

  • Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome

    Anna Virginia Gulino;Daniele Moratto;Silvano Sozzani;Patrizia Cavadini

  • Elevated levels of soluble interleukin 2 receptors in schizophrenia.

    Mark Hyman Rapaport;Cathy G. McAllister;David Pickar;David L. Nelson

  • The Effector Cells in Human Peripheral Blood Mediating Mitogen-Induced Cellular Cytotoxicity and Antibody-Dependent Cellular Cytotoxicity

    Nelson Dl;Bundy Bm;Pitchon He;Blaese Rm

  • In vivo administration of purified human interleukin-2 to patients with cancer: development of interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors following interleukin-2 administration.

    Michael T. Lotze;Mary C. Custer;Susan O. Sharrow;Laurence A. Rubin

Frequent Co-Authors

Warren Strober
Warren Strober National Institute of Allergy and Infectious Diseases
Thomas A. Waldmann
Thomas A. Waldmann National Institutes of Health
William E. Biddison
William E. Biddison National Institutes of Health
Warner C. Greene
Warner C. Greene University of California, San Francisco
Robert Yarchoan
Robert Yarchoan National Institutes of Health
Luigi D. Notarangelo
Luigi D. Notarangelo National Institutes of Health
Fabio Candotti
Fabio Candotti National Institutes of Health
Carolyn K. Goldman
Carolyn K. Goldman National Institutes of Health
William A. Blattner
William A. Blattner University of Maryland, Baltimore
Nicholas S. Hill
Nicholas S. Hill Tufts Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing David L. Nelson

Trending Scientists

Recently Published Articles